QNRX QUOIN PHARMACEUTICALS LTD
FollowSPONSORED ADS (ADR), issuer CIK 1671502
19 managers (19 13F filers) reported a position in QNRX shares at 2026-06-30, 1,299,393 shares in all. 1 filer opened a position and 3 filers sold out during the quarter.
- Managers
- 19
- 13F filers
- 19
- New
- 1
- Added
- 9
- Reduced
- 3
- Sold out
- 3
- Shares held by filers
- 1,299,393
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- INTEGRATED CORE STRATEGIES (US) LLC
8,396,903 shares, 4.99% in a 13G/A as of 2026-09-30,0001104659-26-128525
Accepted , ingested - Ikarian Capital, LLC(group Ikarian Capital, LLC)
211,538 shares, 4.4% in a 13G/A as of 2026-09-30,0001778253-26-000004
Accepted , ingested - STEMPOINT CAPITAL LP(group STEMPOINT CAPITAL LP)
506,983 shares, 9.9% in a 13G as of 2026-09-30,0001104659-26-127778
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 214,987 | $1.04M | 1.8% | +18,395 | 13F-HRTimelineThe filing omitted confidential holdings, a later amendment may add them. |
| Ikarian Capital, LLCin group Ikarian Capital, LLC | 211,538 | $1.02M | 0.17% | 0 | 13F-HRTimelineGroup |
| Stonepine Capital Management, LLCin group Stonepine Capital Management,… | 199,486 | $966K | 0.74% | +146,026 | 13F-HR/ATimelineGroup |
| MILLENNIUM MANAGEMENT LLCin group MILLENNIUM MANAGEMENT LLC | 112,323 | $544K | <0.01% | +36,076 | 13F-HRTimelineGroup |
| SummitTX Capital, L.P. | 100,300 | $485K | 0.01% | 0 | 13F-HRTimeline |
| Woodline Partners LP | 76,446 | $370K | <0.01% | -3,136 | 13F-HRTimeline |
| Aberdeen Group plcin group Aberdeen Group plc | 75,000 | $363K | <0.01% | 0 | 13F-HRTimelineGroup |
| Soleus Capital Management, L.P.in group Soleus Capital Management, L.… | 72,730 | $352K | 0.01% | 0 | 13F-HRTimelineGroup |
| AIGH Capital Management LLCin group AIGH Capital Management LLC | 70,000 | $339K | 0.03% | +19,000 | 13F-HRTimelineGroup |
| BOOTHBAY FUND MANAGEMENT, LLC | 59,838 | $290K | 0.01% | 0 | 13F-HRTimeline |
| Velan Capital Investment Management LP | 32,372 | $157K | 0.1% | -52,477 | 13F-HRTimeline |
| BARCLAYS PLCin group BARCLAYS PLC | 21,469 | $104K | <0.01% | +20,169 | 13F-HRTimelineGroup |
| Birchview Capital, LP | 20,000 | $96.8K | 0.05% | 0 | 13F-HRTimeline |
| XTX Topco Ltdin group XTX Topco Ltd | 15,006 | $72.6K | <0.01% | new | 13F-HRTimelineGroup |
| MORGAN STANLEYin group MORGAN STANLEY | 8,000 | $38.7K | <0.01% | +4,000 | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 6,772 | $32.8K | <0.01% | +4,260 | 13F-HRTimelineGroup |
| RHUMBLINE ADVISERS | 2,332 | $11.3K | <0.01% | +811 | 13F-HRTimeline |
| GAMMA Investing LLC | 439 | $2.12K | <0.01% | -1,281 | 13F-HRTimeline |
| SBI Securities Co., Ltd. | 355 | $1.72K | <0.01% | +353 | 13F-HRTimeline |
Events
INTEGRATED CORE STRATEGIES (US) LLC and 3 other reporting persons reported 8,396,903 QNRX shares, 4.99% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001104659-26-128525
Accepted , ingestedSTEMPOINT CAPITAL LP and 2 other reporting persons reported 506,983 QNRX shares, 9.9% of the class, as of 2026-09-30, in a 13G filed 2026-11-16. 0001104659-26-127778
Accepted , ingestedLANGER DENNIS reported holdings of QNRX shares in a Form 4/A filed 2026-10-26. 0001104659-26-118917
Accepted , ingestedIkarian Capital, LLC and 1 other reporting person reported 211,538 QNRX shares, 4.4% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-07. 0001778253-26-000004
Accepted , ingested